Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adaptor Proteins, Vesicular Transport | 12 | 2017 | 42 | 4.700 |
Why?
|
| Endothelial Cells | 15 | 2020 | 65 | 3.280 |
Why?
|
| Pulmonary Artery | 4 | 2022 | 43 | 2.100 |
Why?
|
| Lung | 12 | 2017 | 158 | 1.880 |
Why?
|
| Hypertension, Pulmonary | 4 | 2020 | 17 | 1.860 |
Why?
|
| RNA, Long Noncoding | 2 | 2022 | 4 | 1.560 |
Why?
|
| Caveolae | 7 | 2015 | 18 | 1.430 |
Why?
|
| Endocytosis | 7 | 2015 | 17 | 1.430 |
Why?
|
| Mice | 17 | 2021 | 1629 | 1.080 |
Why?
|
| Capillary Permeability | 6 | 2013 | 27 | 1.050 |
Why?
|
| Sex Characteristics | 3 | 2022 | 135 | 1.040 |
Why?
|
| Animals | 23 | 2021 | 4633 | 1.030 |
Why?
|
| Cell Membrane | 5 | 2013 | 106 | 1.010 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2023 | 32 | 0.880 |
Why?
|
| Cell Proliferation | 4 | 2020 | 206 | 0.850 |
Why?
|
| RNA, Small Interfering | 6 | 2017 | 65 | 0.810 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 744 | 0.760 |
Why?
|
| rac1 GTP-Binding Protein | 3 | 2016 | 12 | 0.750 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2015 | 17 | 0.610 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2015 | 22 | 0.610 |
Why?
|
| MAP Kinase Signaling System | 2 | 2019 | 38 | 0.600 |
Why?
|
| ets-Domain Protein Elk-1 | 2 | 2017 | 4 | 0.590 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2017 | 34 | 0.590 |
Why?
|
| Lung Diseases | 1 | 2017 | 46 | 0.580 |
Why?
|
| Vascular Remodeling | 1 | 2017 | 8 | 0.570 |
Why?
|
| Endothelium, Vascular | 7 | 2015 | 64 | 0.570 |
Why?
|
| SOS1 Protein | 1 | 2016 | 4 | 0.560 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2016 | 14 | 0.560 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2013 | 25 | 0.540 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 78 | 0.530 |
Why?
|
| Enzyme Activation | 2 | 2013 | 112 | 0.530 |
Why?
|
| Smad2 Protein | 1 | 2015 | 2 | 0.500 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2015 | 8 | 0.500 |
Why?
|
| Platelet Membrane Glycoproteins | 2 | 2013 | 6 | 0.470 |
Why?
|
| Lung Neoplasms | 2 | 2017 | 636 | 0.470 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2013 | 17 | 0.470 |
Why?
|
| Humans | 21 | 2023 | 29796 | 0.470 |
Why?
|
| Apoptosis | 3 | 2015 | 259 | 0.470 |
Why?
|
| Ceramides | 1 | 2013 | 14 | 0.450 |
Why?
|
| Liposomes | 1 | 2013 | 13 | 0.450 |
Why?
|
| Cells, Cultured | 7 | 2020 | 682 | 0.420 |
Why?
|
| Dynamin II | 1 | 2011 | 2 | 0.400 |
Why?
|
| Mice, Knockout | 5 | 2021 | 310 | 0.390 |
Why?
|
| Down-Regulation | 1 | 2011 | 113 | 0.370 |
Why?
|
| Actins | 2 | 2009 | 45 | 0.350 |
Why?
|
| Gene Knockdown Techniques | 3 | 2015 | 42 | 0.340 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2009 | 4 | 0.340 |
Why?
|
| Qb-SNARE Proteins | 2 | 2005 | 4 | 0.320 |
Why?
|
| Qc-SNARE Proteins | 2 | 2005 | 4 | 0.320 |
Why?
|
| Microscopy, Fluorescence | 5 | 2013 | 89 | 0.320 |
Why?
|
| Microscopy, Electron | 5 | 2013 | 75 | 0.310 |
Why?
|
| Exocytosis | 1 | 2007 | 4 | 0.300 |
Why?
|
| Rats | 4 | 2019 | 873 | 0.290 |
Why?
|
| Mitochondria | 1 | 2007 | 84 | 0.280 |
Why?
|
| Qa-SNARE Proteins | 1 | 2005 | 7 | 0.260 |
Why?
|
| Membrane Fusion | 1 | 2005 | 29 | 0.250 |
Why?
|
| Cholesterol | 1 | 2005 | 54 | 0.250 |
Why?
|
| Cell Line | 3 | 2015 | 299 | 0.250 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2023 | 5 | 0.230 |
Why?
|
| Carrier Proteins | 1 | 2003 | 99 | 0.220 |
Why?
|
| Male | 8 | 2021 | 15843 | 0.210 |
Why?
|
| Protein Structure, Tertiary | 3 | 2013 | 63 | 0.210 |
Why?
|
| Sex Chromosomes | 1 | 2022 | 3 | 0.200 |
Why?
|
| Platelet Activating Factor | 2 | 2013 | 8 | 0.200 |
Why?
|
| RNA, Messenger | 2 | 2013 | 323 | 0.190 |
Why?
|
| Neuropeptides | 2 | 2013 | 30 | 0.190 |
Why?
|
| Female | 4 | 2022 | 16401 | 0.180 |
Why?
|
| Signal Transduction | 3 | 2015 | 492 | 0.180 |
Why?
|
| Indoles | 2 | 2019 | 51 | 0.180 |
Why?
|
| Up-Regulation | 1 | 2021 | 173 | 0.180 |
Why?
|
| Pyrroles | 1 | 2019 | 23 | 0.160 |
Why?
|
| Biotin | 2 | 2011 | 7 | 0.160 |
Why?
|
| Hypoxia | 1 | 2019 | 63 | 0.160 |
Why?
|
| Lung Injury | 3 | 2013 | 10 | 0.150 |
Why?
|
| Intercellular Junctions | 2 | 2008 | 9 | 0.150 |
Why?
|
| Systole | 1 | 2017 | 20 | 0.140 |
Why?
|
| Transduction, Genetic | 1 | 2017 | 18 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2017 | 21 | 0.140 |
Why?
|
| Hypertrophy | 1 | 2017 | 19 | 0.140 |
Why?
|
| Lipids | 1 | 2017 | 36 | 0.140 |
Why?
|
| Time-Lapse Imaging | 1 | 2016 | 8 | 0.140 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 23 | 0.140 |
Why?
|
| Ubiquitination | 1 | 2016 | 11 | 0.140 |
Why?
|
| A549 Cells | 1 | 2016 | 9 | 0.140 |
Why?
|
| Collagen | 1 | 2017 | 102 | 0.140 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 110 | 0.140 |
Why?
|
| Cell Movement | 1 | 2016 | 104 | 0.130 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 107 | 0.130 |
Why?
|
| Disease Progression | 1 | 2019 | 812 | 0.130 |
Why?
|
| Heart Ventricles | 1 | 2017 | 168 | 0.130 |
Why?
|
| Caveolin 1 | 2 | 2005 | 11 | 0.130 |
Why?
|
| Phosphorylation | 2 | 2013 | 159 | 0.130 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 273 | 0.130 |
Why?
|
| Immunoblotting | 2 | 2013 | 52 | 0.130 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2015 | 2 | 0.130 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2015 | 3 | 0.130 |
Why?
|
| Nitric Oxide | 3 | 2005 | 103 | 0.130 |
Why?
|
| Transfection | 2 | 2013 | 128 | 0.120 |
Why?
|
| Nitric Oxide Synthase Type II | 3 | 2011 | 65 | 0.120 |
Why?
|
| Cell Survival | 1 | 2015 | 165 | 0.120 |
Why?
|
| Smoking | 1 | 2015 | 194 | 0.120 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 28 | 0.110 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2013 | 9 | 0.110 |
Why?
|
| Granzymes | 1 | 2013 | 7 | 0.110 |
Why?
|
| Proteolysis | 1 | 2013 | 13 | 0.110 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2013 | 2 | 0.110 |
Why?
|
| Cations | 1 | 2013 | 16 | 0.110 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2013 | 7 | 0.110 |
Why?
|
| Gene Silencing | 1 | 2013 | 23 | 0.110 |
Why?
|
| Endothelium | 1 | 2013 | 14 | 0.110 |
Why?
|
| Gene Deletion | 1 | 2013 | 41 | 0.110 |
Why?
|
| Models, Animal | 1 | 2013 | 128 | 0.110 |
Why?
|
| Analysis of Variance | 1 | 2013 | 325 | 0.110 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 256 | 0.100 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 411 | 0.100 |
Why?
|
| src Homology Domains | 1 | 2011 | 2 | 0.100 |
Why?
|
| Clathrin | 1 | 2011 | 3 | 0.100 |
Why?
|
| GTP Phosphohydrolases | 1 | 2011 | 3 | 0.100 |
Why?
|
| Phenotype | 1 | 2013 | 362 | 0.100 |
Why?
|
| Heat-Shock Proteins | 1 | 2011 | 7 | 0.090 |
Why?
|
| Calcification, Physiologic | 1 | 2011 | 21 | 0.090 |
Why?
|
| Skull | 1 | 2011 | 25 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2011 | 175 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 163 | 0.090 |
Why?
|
| Lipopolysaccharides | 1 | 2011 | 129 | 0.090 |
Why?
|
| Extracellular Matrix | 1 | 2011 | 75 | 0.090 |
Why?
|
| Osteoblasts | 1 | 2011 | 63 | 0.090 |
Why?
|
| Cell Differentiation | 1 | 2011 | 149 | 0.090 |
Why?
|
| Wiskott-Aldrich Syndrome Protein | 1 | 2009 | 2 | 0.090 |
Why?
|
| Actin-Related Protein 2-3 Complex | 1 | 2009 | 2 | 0.090 |
Why?
|
| Pseudopodia | 1 | 2009 | 5 | 0.090 |
Why?
|
| Cadherins | 2 | 2008 | 31 | 0.080 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2008 | 4 | 0.080 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2008 | 7 | 0.080 |
Why?
|
| Inflammation | 1 | 2011 | 347 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 4 | 2015 | 436 | 0.080 |
Why?
|
| Nitric Oxide Synthase | 2 | 2005 | 47 | 0.080 |
Why?
|
| Biological Transport | 1 | 2007 | 44 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2007 | 16 | 0.070 |
Why?
|
| Cytochromes c | 1 | 2007 | 15 | 0.070 |
Why?
|
| Receptors, Lysophospholipid | 1 | 2007 | 1 | 0.070 |
Why?
|
| Base Sequence | 1 | 2007 | 131 | 0.070 |
Why?
|
| Albumins | 2 | 2005 | 35 | 0.070 |
Why?
|
| Monocytes | 1 | 2007 | 111 | 0.070 |
Why?
|
| Cell-Free System | 1 | 2005 | 3 | 0.070 |
Why?
|
| Streptavidin | 1 | 2005 | 3 | 0.070 |
Why?
|
| SNARE Proteins | 1 | 2005 | 14 | 0.060 |
Why?
|
| GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2005 | 1 | 0.060 |
Why?
|
| Vesicular Transport Proteins | 1 | 2005 | 9 | 0.060 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2003 | 5 | 0.060 |
Why?
|
| Cell Compartmentation | 1 | 2003 | 11 | 0.060 |
Why?
|
| Dynamins | 1 | 2003 | 10 | 0.060 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 33 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 132 | 0.060 |
Why?
|
| Models, Molecular | 1 | 2003 | 82 | 0.050 |
Why?
|
| Chemokines | 1 | 2002 | 29 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2003 | 463 | 0.050 |
Why?
|
| Sepsis | 1 | 2002 | 147 | 0.050 |
Why?
|
| Phosphoproteins | 2 | 2011 | 28 | 0.040 |
Why?
|
| Protein Binding | 2 | 2011 | 124 | 0.040 |
Why?
|
| Brain | 1 | 2007 | 1726 | 0.040 |
Why?
|
| Antigens, CD | 2 | 2008 | 102 | 0.040 |
Why?
|
| NG-Nitroarginine Methyl Ester | 2 | 2005 | 7 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 2015 | 28 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2007 | 282 | 0.030 |
Why?
|
| Mutation | 2 | 2007 | 395 | 0.030 |
Why?
|
| Enzyme Stability | 1 | 2013 | 5 | 0.030 |
Why?
|
| Integrases | 1 | 2013 | 3 | 0.030 |
Why?
|
| Body Fluids | 1 | 2013 | 19 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2013 | 49 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2011 | 20 | 0.020 |
Why?
|
| Calcium Phosphates | 1 | 2011 | 27 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2011 | 27 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2011 | 131 | 0.020 |
Why?
|
| T-Lymphoma Invasion and Metastasis-inducing Protein 1 | 1 | 2008 | 2 | 0.020 |
Why?
|
| Myosin Light Chains | 1 | 2008 | 6 | 0.020 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2008 | 15 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 39 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2008 | 178 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2007 | 6 | 0.020 |
Why?
|
| Retroviridae | 1 | 2007 | 6 | 0.020 |
Why?
|
| Lysophosphatidylcholines | 1 | 2007 | 7 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2007 | 20 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2007 | 149 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2005 | 13 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 2005 | 14 | 0.020 |
Why?
|
| Blood Vessels | 1 | 2005 | 16 | 0.020 |
Why?
|
| Soluble N-Ethylmaleimide-Sensitive Factor Attachment Proteins | 1 | 2005 | 1 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2005 | 3 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2005 | 3 | 0.020 |
Why?
|
| Glycerol | 1 | 2005 | 3 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2005 | 6 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2005 | 45 | 0.020 |
Why?
|
| COS Cells | 1 | 2005 | 35 | 0.020 |
Why?
|
| Plasmids | 1 | 2005 | 43 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 191 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2005 | 116 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2005 | 241 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2005 | 147 | 0.020 |
Why?
|
| Gold Colloid | 1 | 2002 | 2 | 0.010 |
Why?
|
| Nitrates | 1 | 2002 | 9 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 2002 | 18 | 0.010 |
Why?
|
| Tyrosine | 1 | 2002 | 25 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2002 | 17 | 0.010 |
Why?
|
| Perfusion | 1 | 2002 | 21 | 0.010 |
Why?
|
| Chemokine CXCL2 | 1 | 2002 | 2 | 0.010 |
Why?
|
| Nitric Oxide Donors | 1 | 2002 | 7 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2002 | 15 | 0.010 |
Why?
|
| Binding Sites | 1 | 2002 | 75 | 0.010 |
Why?
|
| Escherichia coli Infections | 1 | 2002 | 29 | 0.010 |
Why?
|
| Pulmonary Edema | 1 | 2002 | 18 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2002 | 267 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2002 | 110 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2002 | 80 | 0.010 |
Why?
|
| Myocardium | 1 | 2002 | 145 | 0.010 |
Why?
|
| Neutrophils | 1 | 2002 | 118 | 0.010 |
Why?
|